Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.
企業コードADVB
会社名Advanced Biomed Inc
上場日Mar 06, 2025
最高経営責任者「CEO」- -
従業員数31
証券種類Ordinary Share
決算期末Mar 06
本社所在地401 Ryland St
都市RENO
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号89502
電話番号1862120510823
ウェブサイトhttp://www.advanbiomed.com/
企業コードADVB
上場日Mar 06, 2025
最高経営責任者「CEO」- -
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし